Lobbying client
AERAS
Nonprofit BioTech Company Advancing Vaccine Science for Tuberculosis
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$80,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2013 to 2014
Filings
7 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Report 1st Quarter 2014
|
MWW GROUP | $30,000 reported |
|
2nd Quarter - Termination 2nd Quarter 2014
|
MWW GROUP | $30,000 reported |
|
2nd Quarter - Terminationreplaced 2nd Quarter 2014
|
MWW GROUP | $30,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2014
|
MWW GROUP | $40,000 reported |
|
4th Quarter - Report 4th Quarter 2013
|
MWW GROUP | $20,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2013
|
MWW GROUP | $40,000 reported |
|
Registration 4th Quarter 2013
|
MWW GROUP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| MWW GROUP | 3 | $80,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 3 |
| Budget/Appropriations | BUD | 3 |
| Foreign Relations | FOR | 1 |
| Health Issues | HCR | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.